Dolby Laboratories (DLB) is moving lower after releasing fiscal second-quarter 2026 financial results and providing forward guidance that implied a softer near-term setup. The company projected fiscal Q3 revenue of $295–$325 million and GAAP diluted EPS of $0.19–$0.34, which investors are treating as a sign of reduced visibility and a lower earnings runway into the next quarter. (stocktitan.net)

For fiscal Q2 2026 (quarter ended March 27, 2026), Dolby reported total revenue of $395.6 million and GAAP net income of $95 million, or $0.99 per diluted share. While the quarter showed growth in licensing revenue, the market focus shifted quickly to the magnitude of the Q3 step-down embedded in the company’s outlook and what it suggests about timing of royalty-based revenue. (stocktitan.net)

Dolby’s outlook includes Q3 non-GAAP EPS of $0.56–$0.71 alongside the lower GAAP EPS range, reflecting adjustments such as stock-based compensation and amortization items. The company also reiterated full-year fiscal 2026 revenue guidance of $1.40–$1.45 billion, but traders appear to be discounting the path to those targets given the stated uncertainty around royalty-based revenue timing and broader macro factors that can affect partner shipments and reporting. (stocktitan.net)

Alongside the results, Dolby declared a $0.36 per share cash dividend payable May 20, 2026 (record date May 12, 2026) and disclosed it repurchased about 1 million shares for roughly $65 million during Q2, with repurchase authorization remaining. The next catalyst is management commentary on the earnings call and any color on licensing cadence across end markets, which could determine whether today’s drop is a one-day reset or the start of a broader de-rating. (stocktitan.net)